Dr. Eunice Wang is the Chief of the Leukemia Service at Roswell Park Cancer Institute. Dr. Wang joined the RPCI faculty in 2003 and was appointed to the Leukemia Service of the Department of Medicine. She earned her medical degree from the Keck School of Medicine, University of Southern California and completed residency training in Internal Medicine at Yale-New Haven Hospital, Yale University, New Haven, CT in 1999. From 1999 to 2003, she completed a clinical hematology-oncology and research fellowship at Memorial Sloan Kettering Cancer Center in New York, NY. Dr. Wang is licensed in New York State and is certified by the American Board of Internal Medicine (Internal Medicine 1999; Medical Oncology, 2002; Medical Hematology, 2004). She also is an Assistant Professor, School of Medicine & Biomedical Sciences, University of Buffalo. She is a member of the American Society of Clinical Oncology, American Association for Cancer Research, and American Society of Hematology. Dr. Wang has authored or co-authored several journal articles, abstracts and book chapters. In addition to her clinical practice, she maintains an active translational laboratory research program into the role of angiogenesis and telomerase in the hematological malignancies.

Role of angiogenesis in promoting the growth of hematological malignancies, Screening anti-angiogenic and other biological agents for effects on clinically relevant human leukemia in vivo, Early stage clinical trials for acute leukemia